Delivery Order SPE2DB20D2104-SPE2DB24FQ96Y
- Not listed
- This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,306.58 firm fixed-price delivery order is for the supply of Olmesartan-HCTZ 40-12.5 mg tablets, with a period of performance through November 13, 2023. This order is part of AmerisourceBergen's large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,945.39, is for the supply of Olmesartan-HCTZ 40-12.5 mg tablets in 90-count packages. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and the contract is a firm-fixed-price delivery order with a performance period...
- This is a $2,742.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Olmesartan Medoxomil 40 mg tablets. The award has a period of performance through May 9, 2025 and was not set aside for any socioeconomic category. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive...
- This federal contract award to AmerisourceBergen Drug Corp is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 through November 2026. The contract provides for the delivery of 4,563,155,110 units of Olmesartan Medoxomil 40 mg tablets in 90-count bottles, with a ceiling value of $5,059.29 and a completion date of December 21, 2023. The award is not designated as a set-aside contract....
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,756.35 firm-fixed-price delivery order covers the supply of Olmesartan Medoxomil 40 mg tablets. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Olmesartan Medoxomil 20 mg tablets in 90-count packages, with a ceiling value of $2,333.76 and a performance period through December 17, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a...
- This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order worth $2,033.37 from the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of 4566035861 - Olmesartan-HCTZ 40-25 mg tablets, a generic blood pressure medication, to support military treatment programs and facilities. This award is not associated with a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a $1,418.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Olmesartan-HCTZ 40-12.5 mg tablets in 30-count packages. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,630.67 delivery order contract covers the supply of Olmesartan-HCTZ 20-12.5 mg tablets in 90-count packages. The contract has an ultimate completion date of November 22, 2024 and uses a firm fixed price pricing type. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply Olmesartan Medoxomil 40 mg tablets. The contract is a delivery order with a firm fixed price of $2,379.19 and a period of performance through January 17, 2025. The contract is not associated with a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FQ96YDelivery Order
This is a delivery order under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,659.68, is for the delivery of Olmesartan-HCTZ 40-12.5 mg tablets in 30-count packages. This award is not designated as a set-aside contract. The IDC held by AmerisourceBergen with the DLA Troop Support Medical is valued at $999,999,999 and runs through November 2026, providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is part of the company's broader contracting efforts with various federal agencies, including the Department of Justice Federal Bureau of Investigation, to supply essential medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.7k | 10/31/23 |